News | May 05, 2026
SK Capital sells Noramco assets to Siegfried
Keeps Halo Pharma to drive independent growth
Keeps Halo Pharma to drive independent growth
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
The investment case for health technology in India is frequently overstated in one direction and understated in another
NewCo’s pipeline includes five investigational medicines
Founded in 2023, Spectrum Vascular acquired the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024
The freshly infused capital will primarily be deployed towards expansion and research & development
Investment will fund expansion to meet rising demand for CRDMO services
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
Subscribe To Our Newsletter & Stay Updated
